Industrial Adhesives
Krayden Sylgard 527 Silicone Dielectric Gel | 2lb
Sylgard 527 Silicone Dielectric Gel is a two component, room temperature and heat curing gel that is used for coating, encapsulating, potting, and sealing electronic devices. It provides flexibility, good flow, and low viscosity.
FOCUS BIOMOLECULES Biochemical Reagents, PT-179, Thalidomide analog molecular glue, CAS 2924858-25-1, 98% by HPLC/NMR (Conforms)
Biochemical Reagents, PT-179, Thalidomide analog molecular glue, CAS 2924858-25-1, 98% by HPLC/NMR (Conforms), PT-179 is an orthogonal thalidomide analog that binds cereblon (CRBN: KD 587 nM/ pomalidomide KD 500 nM) with greatly reduced off-target activity compared to pomalidomide. Pomalidomide induced differential expression of 1426 genes in MM.1S multiple myeloma cells compared to only 3 for PT-179. PT-179 is an interesting new tool for exploring CRBN-based therapeutics.
Grainger TAPECASE Double Sided Foam Tape, White
The TAPECASE Double Sided Foam Tape is a white, double-sided adhesive tape made of polyethylene foam. It has an acrylic adhesive and is 0.045 inches thick with a width of 1 inch. The tape can bond a variety of surfaces including wood, plastic, glass, and metal. It has high tack and is designed for permanent bonding for both indoor and outdoor applications. The tape resists UV rays, moisture, and extreme temperatures. It can be used for mounting signs, attaching molding or trim, and other bonding projects. The tape comes in a 33 yard roll and is made in the USA.
Uline 1/2 LOW PROFILE GLUE DOT SHEET
1/2IN LOW PROFILE GLUE DOT SHEETS Tape and Adhesives 2 000/pack
FOCUS BIOMOLECULES Biochemical Reagents, PT-179, Thalidomide analog molecular glue, CAS 2924858-25-1, 98% by HPLC/NMR (Conforms)
Biochemical Reagents, PT-179, Thalidomide analog molecular glue, CAS 2924858-25-1, 98% by HPLC/NMR (Conforms), PT-179 is an orthogonal thalidomide analog that binds cereblon (CRBN: KD 587 nM/ pomalidomide KD 500 nM) with greatly reduced off-target activity compared to pomalidomide. Pomalidomide induced differential expression of 1426 genes in MM.1S multiple myeloma cells compared to only 3 for PT-179. PT-179 is an interesting new tool for exploring CRBN-based therapeutics.
